The erythropoietin (Epo) receptor belongs to the cytokine receptor superfamily. Although the cytokine receptors do not possess a tyrosine kinase consensus sequence in the intracellular domain, rapid stimulation of a tyrosine kinase activity occurs after activation by the ligand. We and others have shown that Epo induces the tyrosine phosphorylation of its cognate receptor as well as phosphorylation of other proteins. In this report, we examined the role of the receptor tyrosine residues in signal transduction. Eight tyrosine residues are located within the intracellular domain of the murine Epo receptor. A single tyrosine residue is present in the region previously shown to be sufficient for proliferative signal transduction. This tyrosine (Tyr 343) was mutated to phenylalanine. Moreover, mutant receptors were also generated with either a tyrosine residue or a phenylalanine residue at position 343 and with a COOH terminal truncation that removed the 7 other tyrosine residues. Expression vec-RYTHROPOIETIN (Epo) is a kidney-produced hormone that regulates erythropoiesis mainly by controling the survival, proliferation, and differentiation of the late erythroid progenitors, the so-called colony forming units-erythroid (Cm-E; see Koury and Bondurantl for a recent review concerning Epo). Epo action is initiated on these cells by binding to a low number of high-affinity cell surface receptors.' Epo cross-linking on the cell surface of erythroid cells has shown that the Epo receptor (Epo-R) is probably a multimeric complex.'-6 One protein of this complex was cloned in 1989 by D'Andrea et al.' This protein belongs to the growing family of cytokine receptor^^'^ that includes the receptors for other hematopoietic growth factors such as interleukins (ILs) and colony-stimulating factors (CSFs) together with receptors for nonhematopoietic stimulators such as prolactin, growth hormone, and ciliary neurotrophic factor." These receptors do not contain protein kinase consensus sequences in their cytoplasmic domains; however, ligand binding to these receptors quickly induces the tyrosine phosphorylation of proteins in sensitive cells." tors carrying these mutated receptors were transfected into the interleukin-3-dependent murine cell line Ba/F3. Epo-induced growth was sustained efficiently by all these receptors, although receptors without any tyrosine residues conferred a significantly reduced mitogenic activity. Moreover, all receptors were able to mediate Epo-dependant accumulation of P-globin mRNA. The mutated receptors all induced the tyrosine phosphorylation of several cellular proteins after Epo stimulation. However, the truncated receptors induced the phosphorylation of a reduced number of proteins, suggesting that phosphorylated tyrosines of the receptor could have a role in the recruitment either of a tyrosine kinase or of tyrosine kinase substrate proteins. The receptors were all able to mediate Epo-induced activation of phosphatidylinositol 3-kinase, although truncated receptors no longer bound phosphatidylinositol 3-kinase.
The erythropoietin (Epo) receptor belongs to the cytokine receptor superfamily. Although the cytokine receptors do not possess a tyrosine kinase consensus sequence in the intracellular domain, rapid stimulation of a tyrosine kinase activity occurs after activation by the ligand. We and others have shown that Epo induces the tyrosine phosphorylation of its cognate receptor as well as phosphorylation of other proteins. In this report, we examined the role of the receptor tyrosine residues in signal transduction. Eight tyrosine residues are located within the intracellular domain of the murine Epo receptor. A single tyrosine residue is present in the region previously shown to be sufficient for proliferative signal transduction. This tyrosine (Tyr 343) was mutated to phenylalanine. Moreover, mutant receptors were also generated with either a tyrosine residue or a phenylalanine residue at position 343 and with a COOH terminal truncation that removed the 7 other tyrosine residues. Expression vec-RYTHROPOIETIN (Epo) is a kidney-produced hormone that regulates erythropoiesis mainly by controling the survival, proliferation, and differentiation of the late erythroid progenitors, the so-called colony forming units-erythroid (Cm-E; see Koury and Bondurantl for a recent review concerning Epo). Epo action is initiated on these cells by binding to a low number of high-affinity cell surface receptors.' Epo cross-linking on the cell surface of erythroid cells has shown that the Epo receptor (Epo-R) is probably a multimeric complex.'-6 One protein of this complex was cloned in 1989 by D'Andrea et al. ' This protein belongs to the growing family of cytokine receptor^^'^ that includes the receptors for other hematopoietic growth factors such as interleukins (ILs) and colony-stimulating factors (CSFs) together with receptors for nonhematopoietic stimulators such as prolactin, growth hormone, and ciliary neurotrophic factor." These receptors do not contain protein kinase consensus sequences in their cytoplasmic domains; however, ligand binding to these receptors quickly induces the tyrosine phosphorylation of proteins in sensitive cells." tors carrying these mutated receptors were transfected into the interleukin-3-dependent murine cell line Ba/F3. Epo-induced growth was sustained efficiently by all these receptors, although receptors without any tyrosine residues conferred a significantly reduced mitogenic activity. Moreover, all receptors were able to mediate Epo-dependant accumulation of P-globin mRNA. The mutated receptors all induced the tyrosine phosphorylation of several cellular proteins after Epo stimulation. However, the truncated receptors induced the phosphorylation of a reduced number of proteins, suggesting that phosphorylated tyrosines of the receptor could have a role in the recruitment either of a tyrosine kinase or of tyrosine kinase substrate proteins. The receptors were all able to mediate Epo-induced activation of phosphatidylinositol 3-kinase, although truncated receptors no longer bound phosphatidylinositol 3-kinase. Several tyrosine kinases have been implicated in the mechanism of cytokine receptor action and the Jak family of kinases appears to play a central role in the signalling of most, if not all, receptors of the cytokine receptor family." The activation of these kinases require receptor subdomains also necessary for induction of cell proliferation as described for the Epo-RL3 and overexpression of a kinase-deficient form of Jak2 abbrogates Epo-induced mitogenesis.14 As with the receptors with intrinsic tyrosine kinase activity such as platelet-derived growth factor (PDGF), stem cell factor (SCF), or CSF-1 receptors, the cytokine receptors themselves are most generally tyrosine phosphorylated after ligand stimulation. WeI5 and othersI5"* have shown that the Epo-R is tyrosine phosphorylated after ligand binding. Although the Epo-R seems to be a multimeric complex, only the cloned chain is tyrosine pho~phory1ated.I~ Receptor tyrosine phosphorylation plays a key role for signal transduction in the case of the receptors with intrinsic tyrosine kinase activity. Indeed, the phosphorylated tyrosines constitute binding sites for the SH2 domains of effector proteins such as src, phosphatidylinositol 3-kinase (PI 3-kinase), and phospholipase C y and for adaptator proteins allowing the stimulation of the ras pathway. These tyrosine residues are essential to transduce mitogenic signal^.'^^'^ In the case of the cytokine receptors, the importance of the receptor tyrosines appears to be less clearly defined. Truncated granulocyte colony-stimulating factor (G-CSF) receptors lacking tyrosine residues in their intracellular domains remain able to transduce a mitogenic signal but do not induce the expression of specific Most of the phosphorylated tyrosines of the Epo-R are located terminally in the intracellular domain, in a region previously described as unecessary for proliferative signal transd u~t i o n . '~.~~ However, one tyrosine residue ( T Y~~~' ) is located closer to the transmembrane region. Deletion of the region of the Epo-R around Tylj4' has been shown to decrease" or nearly abbrogate'".'63'6 Epo-induced mitogenicity. The role of tyrosine phosphorylation in the transduction of a differentiation signal has never been tested. To investigate the role of the receptor tyrosine phosphorylation in Epo signal trans- 
MATERIALS AND METHODS

Reagents.
The monoclonal antiphosphotyrosine antibody 4G10 was a generous gift of Dr B. Drucker (Dana-Farber Cancer Institute, Boston, MA). Rabbit anti-Epo-R antibodies were produced as previously described6 and were affinity purified using an agarose-bound antigen column. They immunoprecipitated all the Epo-R mutants used in this study with the same efficiency as tested by immunoprecipitation of solubilized IZ5I-Epo-Epo-R complexes (data not shown). Anti-PI 3-kinase (p85 regulatory protein) antibodies were purchased from Transduction Laboratories (Lexington, KY) and anti-Jak2 antibodies were from Upstate Biotechnology Inc (Lake Placid, NY). Highly purified recombinant human Epo (specific activity, 200,000 U/mg) was a generous gift of Dr M. Brandt (Boehringer Mannheim, Mannheim, Germany).
DNA contructs and expression vectors. The intracellular domain of the murine Epo-R contains 8 tyrosine residues (positions 343, 401, 429, 431, 443, 460, 464, and 479 of the mature protein; Fig  1) . Tyrosine 343 was mutated to a phenylalanine residue by changing the TAC 343 codon into 'ITC using the Kunkel method.27 For this mutation, a BamHI-HindIII restriction fragment was first subcloned in pBluescript KS, mutagenized, and sequenced. An entire Epo-R was reconstituted with the mutagenized fragment and cloned between the Xba I and Cla I sites of pBluescript KS. To remove all the tyrosine residues of the COOH end of the receptor, the HindIIICla I fragment was excised and an adaptator with a stop codon and an EcoRI site was inserted. Finally, all the receptors were cloned between the Kpn I and EcoRI sites of the pXM expression vector.
Cell cultures. Nontransfected B e 3 cells were maintained in RPMI 1640 medium containing 10% fetal calf serum (FCS) and 5% WEHI conditioned medium as a source of IL-3. After transfection and selection, Epo-sensitive cells were maintained in RPMI 1640 medium supplemented with 10% FCS and 2 U/mL Epo. Serum-free cultures were performed in RPMI 1640 medium containing 0. For signal transduction experiments, the cells were grown using 1% WEHI conditioned medium and were starved for 2 to 5 hours by incubation in RPMI 1640 medium containing 0.4% BSA and 20 pg/ mL iron-saturated transferrin. For Epo-R measurements, the cells also were cultured with WEHI conditioned medium but the starvation period was omitted.
Stable transfections. BaF3 cells were transfected by electroporation using a Bio-Rad (Hercules, CA) gene pulser set at 250 V and 960 pF. Fifty micrograms of pXM and 10 pg of a plasmid carrying a puromycin or a neomycin resistance gene were used in each transfection. After 48 hours of incubation into L-3-containing medium, the cells were selected for puromycin or G418 resistance in the presence of IL-3. Simultaneously, cells were also selected for growing in the presence of 2 U/mL of Epo after IL-3 removal. In each transfection experiment, control cells transfected with the resistance gene alone or without plasmid were also submitted to selection. Except when otherwhise indicated, all reported results were obtained using cells selected for their ability to grow under Epo stimulation.
Cell proliferation assays. Cell proliferation was measured by the colorimetric assay using 3-(4,5-dimethylthiaz01-2-y1)-2,5,-diphenyltetrazolium bromide using 5 X 10' cells per well in 96-well plates and a 4-hour pulse of M l T after 72 hours of culture with the growth factors.
Receptor measurement. Epo was iodinated using Iodogen (Pierce, Rockford, IL), as previously described: with specific radioactivities ranging from 30 to 60 lo6 cprdpg. Epo binding experiments, Scatchard analysis, and chemical cross-linking were performed as previously de~cribed.~.',~ Immunoprecipitation and Western blotting. Immunoprecipitations and Western blots were performed as previously de~cribed.'~ ECL (Amersham Ltd, Les Ullis, France) was used for the Western blot revelations.
PI 3-kinase assays. PI 3-kinase assays were performed using antiphosphotyrosine immunoprecipitates as previously de~cribed.'~ Association between PI 3-kinase and Epo-R was tested by immunoprecipitation of receptor-bound '*'I-Epo as previously rep~rted.'~ Globin mRNA measurements. RNA extraction and Northern blot analysis were performed as previously reported."
RESULTS
Mitogenic activiry of Epo-R mutants.
To explore the role of the tyrosine residues of the cytoplasmic domain of the Epo-R, we constructed three Epo-R mutants (Fig 1) . Ty1343 in the cytoplasmic domain of the wild-type Epo-R was substituted by a phenylalanine residue to create the ''Phe' ' mutant. The "Stop" mutant retained only Ty?" after removal of the 109 last amino acids. The "Zero" mutant did not possess any tyrosine residue in the intracellular domain after the mutation to phenylalanine of the Ty843 in the Stop mutant. These three mutants as well as the wild-type Epo-R (N) were cloned in the expression vector pXM and introduced by electroporation into B a F 3 cells. The pXM plasmids carrying the mutated receptors were cotransfected with pBabe plasmids carrying either a neomycin or a puromycin resistance gene. Transfected Zero mutant. However, when cells transfected with the Zero mutant were immediately selected for Epo sensitivity instead of antibiotic resistance, cells able to grow in Epo were always obtained in 5 independent transfections. Epo-sensitive cells could never be isolated from untransfected cells or from cells transfected with the neomycin or puromycin selection vector regardless of the selection method and untransfected cells were Epo unresponsive even at high Epo concentrations (Fig  2) . Epo dose-response curves showed that the Phe and Stop mutants conferred Epo sensitivity similar to that observed with the wild-type receptor, whereas the Epo sensitivity of cells transfected with the Zero mutant was slightly depressed. To determine whether our results were also applicable to other IL-3-dependent cell lines, FDCP-1 cells were transfected with the wild-type Epo-R or the Zero mutant and transfected cells were selected for their ability to grow in Epo. In both cases, Epo-sensitive cells were obtained. Moreover, as observed for Ba/F3 cells, FDCP-1 cells transfected with the Zero Epo-R mutant showed an Epo sensitivity lower than that found in cells transfected with the wild-type Epo-R (data not shown). In serum-free medium, Epo was also able to sustain long-term growth (>3 weeks) of BaR3 cells transfected with each of the receptor forms (data not shown). The Zero mutant differed from the Stop mutant only by a GOBERT ET AL single base mutation; to rule out the possibility that revertants had been selected, mRNAs from Epo-sensitive cells were isolated and the sequence encoding the intracellular domain was reverse-transcripted, amplified by polymerase chain reaction (PCR), and sequenced. Cells transfected with the Phe mutant were likewise analyzed. The sequences did not show any modification from the transfected cDNA, demonstrating that no reversion had occurred.
Epo-induced P-globin mRNA accumulation. It has been previously described that BaF3 cells transfected with Epo-R synthesized P-globin mRNA when the cells were grown in EPO.~'. 
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cells transfected with truncated receptors (Stop or Zero), the overall tyrosine phosphorylation pattern induced by Epo was strongly reduced and Western blots mainly showed the Epostimulated tyrosine phosphorylation of the 145-and the 130-kD proteins. Moreover, the tyrosine phosphorylation of protein(s) migrating as a diffuse band between 98 and 90 kD was also stimulated by Epo in cells transfected with the Stop mutant, whereas it was barely detectable in cells expressing the Zero mutant. To investigate whether the Jak2 kinase corresponded to the 130-kD tyrosine phosphorylated protein, cell lysates immunoprecipitated with an anti-Jak2 antibody were analyzed by Western blot using antiphosphotyrosine antibodies. As shown in Fig 6, Jak2 was tyrosine phosphorylated in Epo-stimulated BalF3 cells transfected with the normal or the mutated Epo-Rs.
To study the tyrosine phosphorylation of the Epo-R mutants characterized by a reduced number of tyrosine residues, several experiments were performed. First, Epo-Rs from Epo stimulated or unstimulated cells were immunoprecipitated using anti-Epo-R antibodies and the immunoprecipitated material was analyzed by Western blot using antiphosphotyrosine antibodies. Only the tyrosine phosphorylation of N and Phe receptors could be seen (Fig 7A) . Biotinylated Epo33 was also used to stimulate B e 3 cells transfected with the 
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wild-type (N) receptor or the Stop mutant and the Epo-Epo-R complexes were precipitated using agarose-bound streptavidin. Western blots analysis of precipitated material using antiphosphotyrosine antibodies showed the tyrosine phosphorylation of the normal Epo-R but not the tyrosine phosphorylation of the Stop mutant (Fig 7B) . Finally, we immunoprecipitated '2SI-Ep~ cross-linked to its receptor using antiphosphotyrosine antibodies after denaturation of the receptor complex. Again, only N and Phe but not Stop and Zero receptors were recognized by antiphosphotyrosine antibodies (data not shown). Thus, by these three methods, Tyru3 of the Stop mutant appeared to be nonphosphorylated.
PI .%kinase activation by Epo. Activation of PI 3-kinase
has been reported to be involved in signal transduction pathway induced by E~o .~~. " " '~ As shown in Fig 8, all mutated receptors, including the Zero mutant, were able to mediate Epo stimulation of the PI 3-kinase activity. The association between PI 3-kinase and normal or mutated Epo-Rs was tested by immunoprecipitation of '2SI-Ep~ bound to its receptor using anti-PI 3-kinase antibodies.29 Anti-PI 3-kinase antibodies immunoprecipitated Epo-R-bound '251-Ep0 from cells transfected with the normal Epo-R or the Phe mutant but not from cells transfected with the Stop or the Zero mutants (Fig 9) . Thus, although all mutated receptors mediate Epo-induced activation of the PI 3-kinase, PI 3-kinase associates only with the full-length Epo-Rs (N and Phe) but not with the Stop or the Zero mutants.
DISCUSSION
Tyrosine phosphorylation of receptors with intrinsic tyrosine kinase activity plays a key role in mitogenic signal transduction. Indeed, mutation of the tyrosines of the PDGF or the M-CSF receptor fully abolishes their mitogenic potentia1.'9.2" Most cytokine receptors are also tyrosine phosphorylated after ligand binding, but the role of this phosphorylation is less clearly understood. Our results show that tyrosine phosphorylation of the Epo-R is not required for long-term cell proliferation of BalF3 cells, even in serum-free conditions. However, Epo-responsive B e 3 cells transfected with a receptor devoid of tyrosine residues in the cytoplasmic domain exhibited a lower Epo sensitivity and expressed an higher number of Epo-Rs than did B e 3 cells transfected with the other tested Epo-Rs. The data presented in Fig 2 For personal use only. of Tyr"' . In contrast, the Stop mutant that only retained the Tyr' ' conferred to transfected cells an Epo sensitivity similar to that conferred by the wild-type receptor. However, the only difference between Stop and Zero mutants is T Y~'~' , which did not appear to be phosphorylated in Ba/F3 cells. We cannot rule out that the tyrosine to phenylalanine replacement could modify the local conformation of a region important for signal transduction. However, this latter explanation seems unlikely because the Phe mutant that carried the same substitution conferred to transfected cells an Epo sensitivity similar to that conferred by the wild-type receptor. Alternatively, TyrM3 could be tyrosine phosphorylated in the Stop mutant, but our methods were not sensitive enough to allow its detection. Interestingly, the sequence after the T Y~'~' (YLVL) of the Stop mutant is close to that after the tyrosine residues 429 (YLYL) or 431 (YLVV) of the Phe mutant; it is therefore possible that compensatory mechanisms could occur when one or the other tyrosine is removed in the Phe or Stop mutant. Such a mechanism was recently described for the epidermal growth factor receptor." A recent paper of Yoshimura"' reported the expression of endogenous Epo-R in Ba/F3 cells expressing chimaeric receptors and Table 1 indicated that half-maximum stimulation of cell growth required the occupancy of 10-fold more Zero mutant receptors than wild-type receptors. Previous studies using deletion mutants have shown that Epo-Rs truncated before T y P 3 were unable to transduce a mitogenic signal in DA-3 cells,"*'6 but they stimulated the proliferation of LyD9 cells, another pro-B-cell line, with a reduced effi~iency.'~ These discrepancies could reflect different requirements for these two cell lines to proliferate but, according to our results, they could also reflect different selection mechanisms of Epo-sensitive cells. The reduced efficiency of the truncated Epo-R mutant in LyD9 cells is similar to that we observed for the Zero mutant and could be explained by the absence EPO -+ -+ -+ -+ -+ " " " ." Tyrosine phosphorylation of the tyrosine kinase Jaw. Balm cells transfected with normal or mutated Epo-Rs were stimulated or not for 5 minutes with 5 U/mL Epo. The cells were then solubilized and the extracts were immunoprecipitated using antiJak2 antibodies. After extensive washing, precipitated materials were separated by polyacrylamide gel electrophoresis and blotted to nitrocellulose. The blot was probed using affinity-purified antiphosphotyrosine antibodies.
transfected with the Stop or the Zero mutant Epo-R and selected for their ability to grow in Epo would express less than 30 to 50 endogenous receptors per cells, if any.
All mutant receptors were able to associate with the 85-kD Epo-R accessory protein (p85) previously described in erythroid cells. We have shown that antibodies directed against the intracellular domain of the cloned chain of the Epo-R do not directly recognize ~8 5 .~ This finding suggests that p85 is associated with but is not related to the cloned chain. The apparent molecular mass of p85 did not change after cell transfection with a truncated Epo-R (Fig 4) , confirming that this protein did not derive from the transfected cDNA. Epo cross-linking to this protein was not increased in cells overexpressing Epo-R like the cells transfected with the Zero mutant, suggesting that this protein could be expressed in limiting amounts in Ba/F3 cells.
It has been shown that Ba/F3 cells first described as pro-B cells3' seems to be rather close to erythroid cells.4° Indeed, these cells also expressed erythroid-specific transcription factors such as GATA-1 and SCL and synthesized &globin mRNA when Epo-R-transfected Ba/F3 cells were grown in Epo.".'* Our results confirm these observations and we show that all receptor mutants, including the Zero mutant, were able to mediate Epo-stimulated &globin accumulation. Thus, neither the receptor tyrosine phosphorylation nor the receptor COOH terminal region appeared to be required for Epo-induced erythroid differentiation. Using chimeric receptors, Chiba et ap2 have shown that the extracellular domain of the Epo-R was essential for erythroid differentiation. These investigators concluded that the interaction of the extracellular domain of the Epo-R with other membrane components was essential for the transmission of erythroid differentiation signal; the 85-kD Epo cross-linked protein associated with all our Epo-R mutants could be such a protein.
In For personal use only. on October 31, 2017. by guest www.bloodjournal.org From Association between PI 3-kinase and wild-type or mutated Epo-Rs. Ba/F3 cells transfected with normal or mutated Epo-Rs were stimulated for 10 minutes with 1 nmollL '%Epo (nearly 4 UlmL), washed to remove unbound radioactivity, and lysed using 1% Nonidet P40 and the extracts were centrifuged for 20 minutes at 25.0009. Aliquots of the supernatants were immunoprecipitated using either anti-Epo-R or anti-PI 3-kinase antibodies. Anti-Epo-R antibodies immunoprecipitated 'ZSI-Epo-Epo-R complexes with the same efficientcy regardless of the Epo-R mutant (data not shown). The results are expressed as percentage of radioactivity immunoprecipitated by anti-Epo-R antibodies and are means 2 standard deviations from three independent experiments. (Fig 7) and at least part of the 130-kD band corresponded to the Jak2 kinase (Fig 8) . How- ever, in agreement with other studies, much less protein appeared to be tyrosine phosphorylated in cells transfected with the truncated mutants (Stop or Zero), suggesting that a tyrosine kinase and/or protein kinase substrates associate with the distal part of the receptor. Because the truncated receptors transduce both proliferative and differentiation signals, it appears that most of these tyrosine phosphorylated proteins are necessary neither for cell proliferation nor for erythroid differentiation in BaJF3 cells. In cells transfected with the truncated receptor mutants, Epo mainly induced the tyrosine phosphorylation of the Jak2 kinase and of proteins of 145 and 90-98 kD molecular masses, although the tyrosine phosphorylation of the 90-98-kD proteins was strongly decreased in cells transfected with the Zero mutant. The 145-kD protein could correspond to that associated with the Shc protein in Epo-stimulated DA-ER cells42 and the 90-97-kD protein(s) could correspond to the unidentified cytosolic factor (pp100) previously reported to be tyrosine phosphorylated after Epo stimulation:' However, unlike Jak2, specific probes for pp100 and the 145-kD phosphoprotein have not yet been developed. The Jak2 kinase was previously shown to associate with a region of the Epo-R close to the transmembrane domain,'* which is conserved in all our mutants. However, although Jak2 activation appears to be necessary for Epo signal transd~ction,'~ it has been shown to be not sufficient for efficient mitogenesis, which also requires a region of the receptor including T Y~' .~~ Additional transduction pathway(s) activated by Epo via these truncated receptors should be necessary for efficient mitogenesis.
To tentatively identify these transduction pathways, we studied PI 3-kinase activation in BaR3 cells transfected with the Epo-R mutants. PI 3-kinase activation is required for cell For personal use only. on October 31, 2017. by guest www.bloodjournal.org From proliferation activated by several growth factors. 44 We and kinase and its association with the tyrosine phosphorylated Epo-R. However, the mechanism of Epo-induced PI 3-kinase stimulation remains controversial. According to He et al,34 PI 3-kinase is associated with the Epo-R in the absence of ligand and this association involves the membrane-proximal cytoplasmic region including TyP3, whereas, according to Miura et a,36 PI 3-kinase binds to the activated Epo-R through the phosphorylated tyrosine residues of the carboxyl-terminal region, thus to a region dispensable for Epostimulated mitogenicity. Our results show that PI 3-kinase associates with the carboxyl-terminal region of the Epo-R and that Ty843 is not involved in this binding. But our results also show an alternative way for PI 3-kinase activation because Epo also activates this enzyme in Ba/F3 cells expressing the Zero or the Stop Epo-R mutants that do not associate with PI 3-kinase. In view of our results, it is now necessary to determine the importance of PI 3-kinase activation in Epo mechanism of action. 0thers29,34-36 have reported Epo-induced stimulation of PI 3-
